Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Adjuvant Therapy Open Access Journals

An urgent need for adjuvant molecular therapy in pancreatic cancer by utilizing some chemical molecules or inhibitors. The challenge of meeting the expectations of this desired target product profile, a key question arises: how to combine the available treatment regimens and will these treatments are effective against pancreatic cancer? A variety of new investigational efforts have been used mono-targeted therapy, chemotherapy, and surgical resection for the treatment and prevention of pancreatic cancer. Surgical resection also increased the survival rate from 5% to over 25% in pancreatic cancer, but progression to late stage metastasis greatly minimized the impact of surgery, and thus need to be replaced with adjuvant therapies. Once published open access, author’s work will be made available online, ensuring the widest possible exposure of the authors research. Open Access publications are very important for communication of research findings worldwide.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on September, 2024

Top